Medicare Enrolled
Dr. Ravi Patel, MD
Hematology & Oncology · Stuart, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Ravi Patel is a hematology & oncology specialist in Stuart, FL, with 13 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 111,435 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Patel received a total of $22,381 from 89 pharmaceutical and/or device companies across 831 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 6% volume in FL
$22,381 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 144211 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗111,435
Medicare services
Top 6% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
27,750 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 17,800 | $43 | $106 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
15,900 | $0 | $1 |
| Paclitaxel chemotherapy injection | 10,628 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 9,780 | $19 | $38 |
| Iron infusion (Monoferric) | 6,200 | $17 | $51 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
5,002 | $0 | $2 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,257 | $8 | $40 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,180 | $1 | $2 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,593 | $10 | $40 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,500 | $0 | $0 |
| Principal care management for high-risk disease, first 30 minutes This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month. |
1,467 | $65 | $173 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,400 | $6 | $22 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,091 | $101 | $175 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
499 | $2 | $15 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
478 | $107 | $330 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
472 | $1 | $6 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
451 | $24 | $76 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
431 | $13 | $27 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
326 | $15 | $30 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
311 | $14 | $29 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
300 | $1 | $3 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
244 | $52 | $150 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
238 | $59 | $135 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
227 | $53 | $165 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
221 | $99 | $185 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
213 | $16 | $34 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
192 | $13 | $56 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
179 | $23 | $78 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
166 | $11 | $45 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
145 | $1 | $8 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
139 | $27 | $125 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
139 | $144 | $330 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
136 | $144 | $251 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
134 | $6 | $15 |
| PSA test (prostate cancer screening) | 120 | $18 | $37 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
118 | $7 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
99 | $71 | $111 |
| New patient office visit, complex (60-74 min) | 84 | $176 | $364 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
78 | $50 | $105 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
77 | $16 | $50 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
73 | $66 | $130 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
70 | $19 | $38 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
70 | $16 | $48 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
67 | $28 | $100 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
58 | $19 | $54 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
55 | $8 | $15 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 50 | $364 | $1,111 |
| CA 19-9 tumor antigen test A blood test that measures the level of CA 19-9, a substance that can be found in the blood of some people with cancer. This quantitative analysis detects and measures the specific tumor antigen. |
43 | $20 | $42 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $127 | $300 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
34 | $5 | $11 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
32 | $11 | $40 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
24 | $9 | $18 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
20 | $28 | $68 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
13 | $189 | $651 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
12 | $48 | $355 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $109 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
32.4% high complexity
59.2% medium
8.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,381
Total received (2018-2024)
Avg $3,197/year across 7 years
Top 24% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
89
Companies
831
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,760
2023
$4,872
2022
$8,092
2021
$2,912
2020
$814
2019
$730
2018
$202
Payments by company (2024)
PFIZER INC.
$554
Janssen Biotech, Inc.
$308
Daiichi Sankyo Inc.
$255
AstraZeneca Pharmaceuticals LP
$244
E.R. Squibb & Sons, L.L.C.
$216
Celgene Corporation
$201
Novartis Pharmaceuticals Corporation
$181
Medtronic, Inc.
$175
Merck Sharp & Dohme LLC
$170
Regeneron Healthcare Solutions, Inc.
$162
GENZYME CORPORATION
$145
Astellas Pharma US Inc
$143
Incyte Corporation
$142
ABBVIE INC.
$137
Eisai Inc.
$124
Bayer Healthcare Pharmaceuticals Inc.
$115
Ipsen Biopharmaceuticals, Inc
$91
Alexion Pharmaceuticals, Inc.
$90
SUN PHARMACEUTICAL INDUSTRIES INC.
$86
Takeda Pharmaceuticals U.S.A., Inc.
$80
ADC Therapeutics America, Inc.
$74
SERVIER PHARMACEUTICALS LLC
$72
Coherus Biosciences Inc.
$71
Tempus AI, Inc
$69
EMD Serono, Inc.
$62
Genentech USA, Inc.
$61
GlaxoSmithKline, LLC.
$60
Pharmacosmos Therapeutics Inc.
$53
PharmaEssentia USA Corporation
$51
BeiGene USA, Inc.
$44
SOBI, INC
$43
Karyopharm Therapeutics Inc.
$42
Acrotech Biopharma Inc.
$42
RECORDATI_RARE_DISEASES_INC.
$42
ARRAY BIOPHARMA INC
$39
Cumberland Pharmaceuticals, Inc.
$38
ACCORD HEALTHCARE, INC.
$37
Lilly USA, LLC
$28
Kite Pharma, Inc.
$27
Novocure Inc.
$26
Biocon Biologics Inc
$25
Organon Llc
$24
Genmab U.S., Inc.
$21
Fennec Pharmaceuticals, Inc.
$20
Agios Pharmaceuticals, Inc.
$20
Blue Earth Diagnostics Limited
$18
JAZZ PHARMACEUTICALS INC.
$17
TerSera Therapeutics LLC
$15
Top 3 companies account for 23.5% of 2024 payments
All-time payments by company (2018-2024) ›
Laboratory Corporation of America Holdings
$4,095
AstraZeneca Pharmaceuticals LP
$1,776
Janssen Biotech, Inc.
$1,389
PFIZER INC.
$1,274
Celgene Corporation
$913
GENZYME CORPORATION
$804
Genentech USA, Inc.
$751
Astellas Pharma US Inc
$721
Incyte Corporation
$615
Amgen Inc.
$607
E.R. Squibb & Sons, L.L.C.
$579
Novartis Pharmaceuticals Corporation
$561
Lilly USA, LLC
$516
Daiichi Sankyo Inc.
$471
GlaxoSmithKline, LLC.
$432
Merck Sharp & Dohme Corporation
$380
Seagen Inc.
$364
Regeneron Healthcare Solutions, Inc.
$358
Exelixis Inc.
$323
Ipsen Biopharmaceuticals, Inc
$313
Merck Sharp & Dohme LLC
$305
Karyopharm Therapeutics Inc.
$267
JAZZ PHARMACEUTICALS INC.
$224
Eisai Inc.
$212
Pharmacyclics LLC, An AbbVie Company
$210
ABBVIE INC.
$191
Coherus Biosciences Inc.
$189
Bayer HealthCare Pharmaceuticals Inc.
$179
Medtronic, Inc.
$175
SERVIER PHARMACEUTICALS LLC
$165
Sun Pharmaceutical Industries Inc.
$164
ARRAY BIOPHARMA INC
$148
Alexion Pharmaceuticals, Inc.
$145
ADC Therapeutics America, Inc.
$138
Bayer Healthcare Pharmaceuticals Inc.
$136
Jazz Pharmaceuticals Inc.
$113
Mirati Therapeutics, Inc.
$109
Takeda Pharmaceuticals U.S.A., Inc.
$102
Pharmacyclics LLC, an AbbVie Company
$101
AVEO Pharmaceuticals, Inc.
$100
SUN PHARMACEUTICAL INDUSTRIES INC.
$86
Pharmacosmos Therapeutics Inc.
$85
PharmaEssentia USA Corporation
$78
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$78
TerSera Therapeutics LLC
$71
Tempus AI, Inc
$69
Sobi, Inc
$68
EMD Serono, Inc.
$62
Myriad Genetic Laboratories, Inc.
$62
RECORDATI_RARE_DISEASES_INC.
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Agios Pharmaceuticals, Inc.
$52
Deciphera Pharmaceuticals Inc.
$52
PUMA BIOTECHNOLOGY, INC.
$50
Taiho Oncology, Inc.
$49
BeiGene USA, Inc.
$44
SOBI, INC
$43
Acrotech Biopharma Inc.
$42
Cumberland Pharmaceuticals, Inc.
$38
ACCORD HEALTHCARE, INC.
$37
Tolmar, Inc.
$30
Sumitomo Pharma America, Inc.
$27
Kite Pharma, Inc.
$27
Novocure Inc.
$26
Biocon Biologics Inc
$25
Organon Llc
$24
Foundation Medicine, Inc.
$23
Mylan Institutional Inc.
$23
CTI BioPharma Corp.
$22
Acceleron Pharma, Inc.
$22
Seattle Genetics, Inc.
$22
Alnylam Pharmaceuticals Inc.
$22
Genmab U.S., Inc.
$21
Blueprint Medicines Corporation
$21
Fennec Pharmaceuticals, Inc.
$20
EUSA Pharma (US) LLC
$20
G1 Therapeutics, Inc.
$20
Amneal Pharmaceuticals LLC
$19
AbbVie Inc.
$19
Rigel Pharmaceuticals, Inc.
$19
Blue Earth Diagnostics Limited
$18
Teva Pharmaceuticals USA, Inc.
$18
Stemline Therapeutics Inc.
$17
Clovis Oncology, Inc.
$15
ImmunoGen, Inc.
$15
Kyowa Kirin, Inc.
$15
Dova Pharmaceuticals
$12
Acrotech Biopharma LLC
$12
Myovant Sciences Inc.
$11
Top 3 companies account for 32.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AVASTIN · AYVAKIT · Aliqopa · Aranesp · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CARBAGLU · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Enhertu · Epkinly · FOTIVDA · Fulphila · GILOTRIF · GIVLAARI · Hulio · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · LifeVest · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · ONIVYDE · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Odomzo · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PGDX ELIO TISSUE COMPLETE · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Pedmark · Phesgo · Pomalyst · Prolaris · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYZNEUTA · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SOMATULINE DEPOT · SYLVANT · Somatuline Depot · Sylvant · TABRECTA · TAGRISSO · TALVEY · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tecentriq · Tibsovo · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · XALKORI · XOSPATA · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zoladex · myChoice CDx · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
18
County median income
$80,701
Nearest hospital to ZIP centroid (approximate)
CLEVELAND CLINIC MARTIN NORTH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 6% in FL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Patel performed 27,750 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $22,381 from 89 companies across 831 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other hematology & oncology specialists in Stuart?
Dr. Patel's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Stuart
Browse hematology & oncology specialists in Stuart ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Laboratory Corporation of America Holdings Payments to Doctors
See all physicians who received payments from Laboratory Corporation of America Holdings.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology